{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:02:07Z","timestamp":1791468127487,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303669"],"award-info":[{"award-number":["82303669"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403596"],"award-info":[{"award-number":["82403596"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403337"],"award-info":[{"award-number":["82403337"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2026NSFSC1896"],"award-info":[{"award-number":["2026NSFSC1896"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2026NSFSC1673"],"award-info":[{"award-number":["2026NSFSC1673"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2026NSFSC1922"],"award-info":[{"award-number":["2026NSFSC1922"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC1879"],"award-info":[{"award-number":["2025ZNSFSC1879"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.intimp.2026.117501","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:46:47Z","timestamp":1790815607000},"page":"117501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumor-derived acetylcholine promotes immune evasion in hepatocellular carcinoma by protecting regulatory T cells from ferroptosis"],"prefix":"10.1016","volume":"190","author":[{"given":"Fei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2026.117501_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.intimp.2026.117501_bb0010","first-page":"498","article-title":"Advances in the treatment of hepatocellular carcinoma: an overview of the current and evolving therapeutic landscape for clinicians","volume":"75","author":"Moris","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"20","key":"10.1016\/j.intimp.2026.117501_bb0015","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.117501_bb0020","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1097\/JS9.0000000000001479","article-title":"Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: a global-scale, cross-sectional, and large-sample informatics study","volume":"110","author":"Guo","year":"2024","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.intimp.2026.117501_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1431211","article-title":"Regulatory T cells and immune escape in hepatocellular carcinoma: understanding the tumor microenvironment and advancing CAR-T cell therapy","volume":"15","author":"Du","year":"2024","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.intimp.2026.117501_bb0030","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1200\/JCO.2006.09.4565","article-title":"Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection","volume":"25","author":"Gao","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117501_bb0035","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1053\/j.gastro.2007.03.102","article-title":"Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients","volume":"132","author":"Fu","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.intimp.2026.117501_bb0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117501_bb0045","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.7150\/ijbs.96014","article-title":"Current progress of ferroptosis study in hepatocellular carcinoma","volume":"20","author":"Zhu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2026.117501_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1207496","article-title":"Mechanism of sorafenib resistance associated with ferroptosis in hepatocellular carcinoma","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117501_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109235","article-title":"The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity","volume":"35","author":"Xu","year":"2021","journal-title":"Cell Rep."},{"issue":"7755","key":"10.1016\/j.intimp.2026.117501_bb0060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"issue":"7784","key":"10.1016\/j.intimp.2026.117501_bb0065","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"issue":"7784","key":"10.1016\/j.intimp.2026.117501_bb0070","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2026.117501_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tips.2007.12.006","article-title":"Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis","volume":"29","author":"Egleton","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2026.117501_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084564","article-title":"Contributions of non-neuronal cholinergic systems to the regulation of immune cell function, highlighting the role of \u03b17 nicotinic acetylcholine receptors","volume":"25","author":"Kawashima","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2026.117501_bb0085","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/mc.22885","article-title":"\u03b17nAChR-mediated recruitment of PP1\u03b3 promotes TRAF6\/NF-\u03baB cascade to facilitate the progression of hepatocellular carcinoma","volume":"57","author":"Wan","year":"2018","journal-title":"Mol. Carcinog."},{"issue":"3","key":"10.1016\/j.intimp.2026.117501_bb0090","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1124\/jpet.110.169961","article-title":"Stimulation of \u03b17 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro","volume":"335","author":"Wang","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2026.117501_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01102","article-title":"Distinct roles of \u03b17 nAChRs in antigen-presenting cells and CD4+ T cells in the regulation of T cell differentiation","volume":"10","author":"Mashimo","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117501_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s11658-023-00438-9","article-title":"Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance","volume":"28","author":"Hashemi","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"9","key":"10.1016\/j.intimp.2026.117501_bb0105","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41388-021-01660-5","article-title":"The deubiquitinase USP11 regulates cell proliferation and ferroptotic cell death via stabilization of NRF2","volume":"40","author":"Meng","year":"2021","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.intimp.2026.117501_bb0110","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2026.117501_bb0115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.intimp.2026.117501_bb0120","article-title":"The lactate-primed KAT8-PCK2 axis exacerbates hepatic ferroptosis during ischemia\/reperfusion injury by reprogramming OXSM-dependent mitochondrial fatty acid synthesis","volume":"12","author":"Yuan","year":"2025","journal-title":"Adv Sci (Weinh)."},{"key":"10.1016\/j.intimp.2026.117501_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102546","article-title":"HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma","volume":"58","author":"Yuan","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2026.117501_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.990571","article-title":"A novel medication decision gene signature predicts response to individualized therapy and prognosis outcomes in hepatocellular carcinoma patients","volume":"13","author":"Yuan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117501_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117290","article-title":"\u03b17nAChR activation promotes the generation of Treg cells by enhancing the dephosphorylation of Foxo1 via the IP3R\/Ca2+\/calcineurin pathway","volume":"242","author":"He","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"5955","key":"10.1016\/j.intimp.2026.117501_bb0140","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.1172702","article-title":"CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner","volume":"326","author":"Chaudhry","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2026.117501_bb0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.intimp.2026.117501_bb0150","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2026.117501_bb0155","article-title":"Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117501_bb0160","article-title":"Current insights into the hepatic microenvironment and immunotherapy in hepatocellular carcinoma","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117501_bb0165","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molmed.2023.05.013","article-title":"FSP1: a key regulator of ferroptosis","volume":"29","author":"Li","year":"2023","journal-title":"Trends Mol. Med."},{"issue":"7969","key":"10.1016\/j.intimp.2026.117501_bb0170","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","article-title":"Phase separation of FSP1 promotes ferroptosis","volume":"619","author":"Nakamura","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117501_bb0175","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000246","article-title":"Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma","volume":"7","author":"Liu","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.intimp.2026.117501_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217556","article-title":"EBF1-induced CSRP2 boosts the progression of B-cell acute lymphocytic leukemia by inhibiting ferroptosis","volume":"614","author":"Liu","year":"2025","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.intimp.2026.117501_bb0185","first-page":"449","article-title":"Targeting ferroptosis suppressor protein 1 for overcoming ferroptosis resistance","volume":"31","author":"Lee","year":"2023","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.intimp.2026.117501_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102553","article-title":"USP11 is involved in the sensitivity of liver cancer cells to ferroptosis and taxanes through the regulation of NRF2 ubiquitin-mediated degradation","volume":"62","author":"Kong","year":"2025","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117501_bb0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res."},{"issue":"11","key":"10.1016\/j.intimp.2026.117501_bb0200","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","article-title":"Therapeutic targeting of regulatory T cells in cancer","volume":"8","author":"Shan","year":"2022","journal-title":"Trends Cancer"},{"issue":"18","key":"10.1016\/j.intimp.2026.117501_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814114","article-title":"The role of regulatory T cells in cancer treatment resistance","volume":"24","author":"D\u0105browska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.117501_bb0210","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.117501_bb0215","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.gastro.2022.09.005","article-title":"Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma","volume":"164","author":"Haber","year":"2023","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.intimp.2026.117501_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081922","article-title":"Anti-PD-1\/PD-L1 based combination immunotherapy to boost antigen-specific CD8+ T cell response in hepatocellular carcinoma","volume":"13","author":"Pe\u00f1a-Asensio","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"23","key":"10.1016\/j.intimp.2026.117501_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12237469","article-title":"The complexity of the tumor microenvironment in hepatocellular carcinoma and emerging therapeutic developments","volume":"12","author":"Argentiero","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2026.117501_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106758","article-title":"Neuroimmune nexus in the pathophysiology and therapy of inflammatory disorders: role of \u03b17 nicotinic acetylcholine receptors","volume":"191","author":"Keever","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2026.117501_bb0235","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40164-024-00539-x","article-title":"Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside","volume":"13","author":"Yin","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117501_bb0240","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117501_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250002","article-title":"Targeting regulatory T cell metabolism in disease: novel therapeutic opportunities","volume":"53","author":"Halvorson","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2026.117501_bb0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cytogfr.2023.08.004","article-title":"Ferroptosis in cancer immunity and immunotherapy: multifaceted interplay and clinical implications","volume":"75","author":"Zhai","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.intimp.2026.117501_bb0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","article-title":"Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives","volume":"17","author":"Shen","year":"2024","journal-title":"J. Hematol. Oncol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:26:32Z","timestamp":1791465992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926013494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":51,"alternative-id":["S1567576926013494"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117501","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-derived acetylcholine promotes immune evasion in hepatocellular carcinoma by protecting regulatory T cells from ferroptosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117501"}}